Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice1,2[S]
暂无分享,去创建一个
[1] G. FitzGerald,et al. Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions1,2[S] , 2017, Journal of Lipid Research.
[2] D. Engblom,et al. Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain , 2017, The Journal of clinical investigation.
[3] D. Engblom,et al. Cyclooxygenase Isoform Exchange Blocks Brain-Mediated Inflammatory Symptoms , 2016, PloS one.
[4] J. Mitchell,et al. Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] Hailiang Huang,et al. Characterization of candidate genes in inflammatory bowel disease-associated risk loci. , 2016, JCI insight.
[6] Roderick V. Jensen,et al. Genomic, Lipidomic and Metabolomic Analysis of Cyclooxygenase-null Cells: Eicosanoid Storm, Cross Talk, and Compensation by COX-1 , 2016, Genom. Proteom. Bioinform..
[7] J. Cidlowski,et al. Endogenous hepatic glucocorticoid receptor signaling coordinates sex‐biased inflammatory gene expression , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] M. Reilly,et al. Bioactive products formed in humans from fish oils1[S] , 2015, Journal of Lipid Research.
[9] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[10] C. Funk,et al. Cyclooxygenase‐2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4) , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] P. Boor,et al. YB-1 Is an Early and Central Mediator of Bacterial and Sterile Inflammation In Vivo , 2013, The Journal of Immunology.
[12] Myeong Sup Lee,et al. Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells , 2013, Molecules and cells.
[13] M. Ornatowska,et al. Lipopolysaccharide-Induced Expression of Microsomal Prostaglandin E Synthase-1 Mediates Late-Phase PGE2 Production in Bone Marrow Derived Macrophages , 2012, PloS one.
[14] A. A. Romanovsky,et al. Neural Circuitry Engaged by Prostaglandins during the Sickness Syndrome Nih Public Access Author Manuscript Elevated Corticosteroid Levels , 2022 .
[15] F. Di Virgilio,et al. P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Christian Ehlting,et al. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. , 2012, Cellular signalling.
[17] Ying Yu,et al. Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice , 2012, Science Translational Medicine.
[18] A. Matsuda,et al. Pre-Treatment of Recombinant Mouse MFG-E8 Downregulates LPS-Induced TNF-α Production in Macrophages via STAT3-Mediated SOCS3 Activation , 2011, PloS one.
[19] Y. Urade,et al. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. , 2011, Chemical reviews.
[20] N. Kaushal,et al. Selenoprotein-dependent Up-regulation of Hematopoietic Prostaglandin D2 Synthase in Macrophages Is Mediated through the Activation of Peroxisome Proliferator-activated Receptor (PPAR) γ* , 2011, The Journal of Biological Chemistry.
[21] G. Graf,et al. Cyclooxygenase-2 Deficiency Attenuates Adipose Tissue Differentiation and Inflammation in Mice , 2010, The Journal of Biological Chemistry.
[22] G. FitzGerald,et al. Cyclooxygenase-2–Dependent Prostacyclin Formation and Blood Pressure Homeostasis: Targeted Exchange of Cyclooxygenase Isoforms in Mice , 2010, Circulation research.
[23] L. Lindgren,et al. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[24] Ying Yu,et al. Renal and cardiovascular characterization of COX-2 knockdown mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[25] F. Bosetti,et al. Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injury , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] G. FitzGerald,et al. Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality* , 2007, Journal of Biological Chemistry.
[27] G. FitzGerald,et al. Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. , 2005, The Journal of clinical investigation.
[28] R. Botting,et al. Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition , 2004, Pharmacological Reviews.
[29] B. Levy,et al. Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] R. Langenbach,et al. Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. , 2002, Prostaglandins & other lipid mediators.
[31] C. Funk,et al. Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.
[32] M. Murakami,et al. Coupling between Cyclooxygenase, Terminal Prostanoid Synthase, and Phospholipase A2 * , 2001, The Journal of Biological Chemistry.
[33] T. Standiford,et al. Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[34] C. Leslie,et al. Intracellular Calcium Signals Regulating Cytosolic Phospholipase A2 Translocation to Internal Membranes* 210 , 2001, The Journal of Biological Chemistry.
[35] Charles N. Serhan,et al. Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.
[36] B. Koller,et al. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.
[37] R. Langenbach,et al. Why there are two cyclooxygenase isozymes. , 2001, The Journal of clinical investigation.
[38] S A Rich,et al. The coxibs, selective inhibitors of cyclooxygenase-2. , 2001, The New England journal of medicine.
[39] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[40] C. Cerletti,et al. COX-2 is not involved in thromboxane biosynthesis by activated human platelets. , 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[41] R. Langenbach,et al. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. , 1999, Biochemical pharmacology.
[42] R. Langenbach,et al. Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis , 1999, Annals of the New York Academy of Sciences.
[43] R. Kulmacz,et al. Hydroperoxide Dependence and Cooperative Cyclooxygenase Kinetics in Prostaglandin H Synthase-1 and -2* , 1999, The Journal of Biological Chemistry.
[44] G. FitzGerald,et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Wallace,et al. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. , 1998, Gastroenterology.
[46] I. Morita,et al. Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts. , 1998, Biochimica et biophysica acta.
[47] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[48] D. Swinney,et al. Differential Allosteric Regulation of Prostaglandin H Synthase 1 and 2 by Arachidonic Acid* , 1997, The Journal of Biological Chemistry.
[49] J. Johnston,et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.
[50] Hyung-Suk Kim,et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.
[51] R. Langenbach,et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.
[52] J. D. Clark,et al. Cytosolic phospholipase A2. , 1995, Journal of lipid mediators and cell signalling.
[53] T. Kaneko,et al. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] V. Winn,et al. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[55] H R Herschman,et al. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. , 1992, The Journal of biological chemistry.
[56] R. Erikson,et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[57] G. FitzGerald,et al. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.
[58] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.